申请人:Elliott Leonard Richard
公开号:US20060241126A1
公开(公告)日:2006-10-26
Compounds of formula (I):
are inhibitors of the enzyme Lp-PLA
2
and are of use in therapy, in particular for treating atherosclerosis.
公式为(I)的化合物是Lp-P
LA2酶的
抑制剂,可用于治疗,特别是用于治疗动脉粥样硬化。